Literature DB >> 16412096

Increased levels of cyclins D1 and D3 after inhibition of gap junctional communication in astrocytes.

Arantxa Tabernero1, Rosa Sánchez-Alvarez, José M Medina.   

Abstract

We showed previously that the inhibition of gap junctional communication in astrocytes increased bromodeoxyuridine (BrdU) incorporation and promoted changes in the metabolic phenotype destined to fulfil the requirements of cell proliferation. In the present study we investigated the changes in the cell cycle of astrocytes promoted by the inhibition of intercellular communication through gap junctions. Thus, the presence of endothelin-1 and carbenoxolone, two gap junction uncouplers, promoted an increase in the percentage of astrocytes found in the S, G2 and M phases of the cell cycle, with a concomitant decrease in G0 and G1 phases. In addition, the levels of Ki-67, a protein present during all active phases of the cell cycle but absent from resting cells, increased after the inhibition of gap junctional communication. These effects were not observed when the inhibition of gap junctions was prevented with tolbutamide, indicating that the inhibition of gap junctional communication promotes the entry of astrocytes into the cell cycle. The passage of the cells from a quiescent state to the cell cycle is ultimately regulated by the degree of retinoblastoma phosphorylation. Inhibition of gap junctions increased the phosphorylation of retinoblastoma at Ser 780 but not at Ser 795 or Ser 807/811. In addition, the levels of cyclins D1 and D3 increased, whereas those of p21 and p27 were not significantly modified. Because D-type cyclins are key regulators of retinoblastoma protein phosphorylation, it is suggested that the phosphorylation of retinoblastoma protein at Ser 780, observed under our experimental conditions, is a consequence of the increase in the levels of cyclins D1 and D3. Our work provides evidence for the involvement of cyclins D1 and D3 as sensors of the inhibition of gap junctional communication in astrocytes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16412096     DOI: 10.1111/j.1471-4159.2005.03623.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  11 in total

1.  Connexin 30 expression inhibits growth of human malignant gliomas but protects them against radiation therapy.

Authors:  Maria Artesi; Jerome Kroonen; Markus Bredel; Minh Nguyen-Khac; Manuel Deprez; Laurent Schoysman; Christophe Poulet; Arnab Chakravarti; Hyunsoo Kim; Denise Scholtens; Tatjana Seute; Bernard Rogister; Vincent Bours; Pierre A Robe
Journal:  Neuro Oncol       Date:  2014-08-25       Impact factor: 12.300

Review 2.  Biological and biophysical properties of vascular connexin channels.

Authors:  Scott Johnstone; Brant Isakson; Darren Locke
Journal:  Int Rev Cell Mol Biol       Date:  2009       Impact factor: 6.813

Review 3.  Cooperativity and complementarity: synergies in non-classical and classical glucocorticoid signaling.

Authors:  Ranmal A Samarasinghe; Selma F Witchell; Donald B DeFranco
Journal:  Cell Cycle       Date:  2012-08-01       Impact factor: 4.534

Review 4.  The role of gap junction channels during physiologic and pathologic conditions of the human central nervous system.

Authors:  Eliseo A Eugenin; Daniel Basilio; Juan C Sáez; Juan A Orellana; Cedric S Raine; Feliksas Bukauskas; Michael V L Bennett; Joan W Berman
Journal:  J Neuroimmune Pharmacol       Date:  2012-03-23       Impact factor: 4.147

5.  A potential role of connexin 43 in epidermal growth factor-induced proliferation of mouse embryonic stem cells: involvement of Ca2+/PKC, p44/42 and p38 MAPKs pathways.

Authors:  J H Park; M Y Lee; J S Heo; H J Han
Journal:  Cell Prolif       Date:  2008-10       Impact factor: 6.831

6.  Rett syndrome astrocytes are abnormal and spread MeCP2 deficiency through gap junctions.

Authors:  Izumi Maezawa; Susan Swanberg; Danielle Harvey; Janine M LaSalle; Lee-Way Jin
Journal:  J Neurosci       Date:  2009-04-22       Impact factor: 6.167

Review 7.  Endothelin ETB Receptor-Mediated Astrocytic Activation: Pathological Roles in Brain Disorders.

Authors:  Yutaka Koyama
Journal:  Int J Mol Sci       Date:  2021-04-21       Impact factor: 5.923

8.  Liposomal clodronate selectively eliminates microglia from primary astrocyte cultures.

Authors:  Hiromi Kumamaru; Hirokazu Saiwai; Kazu Kobayakawa; Kensuke Kubota; Nico van Rooijen; Kazuhide Inoue; Yukihide Iwamoto; Seiji Okada
Journal:  J Neuroinflammation       Date:  2012-05-31       Impact factor: 8.322

9.  HIF-1 and c-Src mediate increased glucose uptake induced by endothelin-1 and connexin43 in astrocytes.

Authors:  José Carlos Valle-Casuso; Ana González-Sánchez; José M Medina; Arantxa Tabernero
Journal:  PLoS One       Date:  2012-02-23       Impact factor: 3.240

10.  Dynamic changes in protein interaction between AKAP95 and Cx43 during cell cycle progression of A549 cells.

Authors:  Xiaoxuan Chen; Xiangyu Kong; Wenxin Zhuang; Bogang Teng; Xiuyi Yu; Suhang Hua; Su Wang; Fengchao Liang; Dan Ma; Suhui Zhang; Xuan Zou; Yue Dai; Wei Yang; Yongxing Zhang
Journal:  Sci Rep       Date:  2016-02-16       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.